Hudock, Inc. Bristol Myers Squibb CO Transaction History

Hudock, Inc.

$535 Million
Q2 2024

A detailed history of Hudock, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hudock, Inc. holds 5,411 shares of BMY stock, worth $287,811. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,411

Previous 5,404 0.13%

Holding current value

$287,811

Previous $293,000 23.55%

% of portfolio

0.04%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$40.25 - $52.99 $281 - $370	7 Added 0.13%	5,411 $224,000
Q1 2024 May 02, 2024	SELL	$47.98 - $54.4 $37,664 - $42,704	-785 Reduced 12.68%	5,404 $293,000
Q4 2023 Jan 22, 2024	BUY	$48.48 - $57.85 $339 - $404	7 Added 0.11%	6,189 $317,000
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $347 - $388	6 Added 0.1%	6,182 $358,000
Q2 2023 Jul 31, 2023	BUY	$63.71 - $70.74 $318 - $353	5 Added 0.08%	6,176 $394,000
Q1 2023 May 08, 2023	BUY	$65.71 - $74.53 $16,690 - $18,930	254 Added 4.29%	6,171 $427,000
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $68 - $81	1 Added 0.02%	5,917 $425,000
Q3 2022 Nov 02, 2022	BUY	$0.13 - $76.84 $65 - $38,496	501 Added 9.25%	5,916 $420,000
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $14,524 - $15,996	-200 Reduced 3.56%	5,415 $417,000
Q1 2022 May 02, 2022	SELL	$61.48 - $73.72 $2,951 - $3,538	-48 Reduced 0.85%	5,615 $410,000
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $1,501 - $1,750	-28 Reduced 0.49%	5,663 $353,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $43,904 - $51,428	-742 Reduced 11.53%	5,691 $336,000
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $495 - $539	8 Added 0.12%	6,433 $429,000
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $14,122 - $15,884	-238 Reduced 3.57%	6,425 $405,000
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $16,975 - $19,236	294 Added 4.62%	6,663 $413,000
Q3 2020 Oct 23, 2020	BUY	$57.43 - $63.64 $114 - $127	2 Added 0.03%	6,369 $383,000
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $5,536 - $6,473	101 Added 1.61%	6,367 $374,000
Q1 2020 Apr 27, 2020	BUY	$46.4 - $67.43 $3,665 - $5,326	79 Added 1.28%	6,266 $349,000
Q4 2019 Jan 21, 2020	SELL	$49.21 - $64.19 $9,743 - $12,709	-198 Reduced 3.1%	6,187 $391,000
Q3 2019 Oct 31, 2019	BUY	$42.77 - $50.71 $42 - $50	1 Added 0.02%	6,385 $323,000
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $214,800 - $237,522	-4,814 Reduced 42.99%	6,384 $289,000
Q1 2019 Apr 23, 2019	BUY	$45.12 - $53.8 $45 - $53	1 Added 0.01%	11,198 $534,000
Q4 2018 Jan 29, 2019	SELL	$48.76 - $63.23 $3,852 - $4,995	-79 Reduced 0.7%	11,197 $570,000
Q3 2018 Oct 16, 2018	BUY	$55.19 - $62.25 $55 - $62	1 Added 0.01%	11,276 $700,000
Q2 2018 Aug 01, 2018	BUY	$50.53 - $62.98 $4,749 - $5,920	94 Added 0.84%	11,275 $623,000
Q1 2018 Apr 27, 2018	SELL	$59.92 - $68.98 $43,082 - $49,596	-719 Reduced 6.04%	11,181 $707,000
Q4 2017 Jan 30, 2018	BUY	$59.94 - $65.35 $2,697 - $2,940	45 Added 0.38%	11,900 $729,000
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $4,418 - $5,099	80 Added 0.68%	11,855 $755,000
Q2 2017 Aug 08, 2017	BUY	N/A	11,775	11,775 $656,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hudock, Inc. with notifications on news.

Account